Grifols (GIKLY) Change in Account Payables (2010 - 2020)

Grifols (GIKLY) reported Change in Account Payables of -$25.7 million for Q1 2020, up 53.91% on a YoY basis from -$16.7 million in Q2 2019, and up 67.14% quarter-over-quarter from -$78.2 million in Q4 2019.

Grifols (GIKLY) Change in Account Payables (2010 - 2020) Analysis & Trends

Grifols has reported Change in Account Payables for 10 years, with the latest figure at -$25.7 million in Q1 2020.

  • For the quarter ending Q1 2020, Change in Account Payables rose 53.91% year-over-year to -$25.7 million; the trailing twelve-month figure through Mar 2020 stood at -$155.5 million (down 134.7% YoY), and the FY2025 full-year result was $109.4 million, up 253.09% from the prior year.
  • Change in Account Payables for Q1 2020 stood at -$25.7 million, up from -$78.2 million in the prior quarter.
  • The five-year high for Change in Account Payables was $81.5 million in Q4 2016, with the low at -$78.2 million in Q4 2019.
  • Historically, Change in Account Payables has averaged -$5.2 million across 5 years, with a median of $4.2 million in 2018.
  • Annual changes were most pronounced in 2016 — Change in Account Payables jumped 128.83% — and 2019, when it plunged 1957.3%.
  • Grifols' Change in Account Payables stood at $81.5 million in 2016, then slumped by 40.67% to $48.3 million in 2017, then tumbled by 91.29% to $4.2 million in 2018, then sank by 1957.3% to -$78.2 million in 2019, then jumped by 67.14% to -$25.7 million in 2020.
  • The last three Change in Account Payables figures came in at -$25.7 million (Q1 2020), -$78.2 million (Q4 2019), and -$55.8 million (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 571.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -67.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 409.00 Mn
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -25.70 Mn
Mar 31, 2020 -25.70 Mn
Dec 31, 2019 -78.22 Mn
Dec 31, 2019 -78.22 Mn
Mar 31, 2019 -55.77 Mn
Mar 31, 2019 -55.77 Mn
Dec 31, 2018 4.21 Mn
Dec 31, 2018 4.21 Mn
Jun 30, 2018 -22.71 Mn
Jun 30, 2018 -22.71 Mn
Mar 31, 2018 8.02 Mn
Mar 31, 2018 8.02 Mn
Dec 31, 2017 48.35 Mn
Dec 31, 2017 48.35 Mn
Jun 30, 2017 34.54 Mn
Jun 30, 2017 34.54 Mn
Mar 31, 2017 19.09 Mn
Mar 31, 2017 19.09 Mn
Dec 31, 2016 81.49 Mn
Dec 31, 2016 81.49 Mn